General Atomics, Nordion to Get Phase II Funds from DOE to Support Medical Isotope Production
General Atomics and Nordion will receive $15.3 million in funds from the Energy Department under the second phase of a cooperative agreement to produce commercial supplies of molybdenum-99 isotopes with the University of Missouri Research Reactor Center. Nordion said Wednesday the Phase II funds from DOE’s National Nuclear Security Administration came more than a year after NNSA awarded $9.7 […] More